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IMPORTANCE Prion diseases represent the archetype of brain diseases caused by protein
misfolding, with themost common subtype being sporadic Creutzfeldt-Jakob disease (sCJD),
a rapidly progressive dementia. Diffusion-weighted imaging (DWI) has emerged as themost
sensitive magnetic resonance imaging (MRI) sequence for the diagnosis of sCJD, but few
studies have assessed the evolution of MRI signal as the disease progresses.
OBJECTIVES To assess the natural history of the MRI signal abnormalities on DWI in sCJD to
improve our understanding of the pathogenesis and to investigate the potential of DWI as a
biomarker of disease progression, with histopathological correlation.
DESIGN, SETTING, AND PARTICIPANTS Graymatter involvement on DWIwas assessed among
37 patients with sCJD in 26 cortical and 5 subcortical subdivisions per hemisphere using a
semiquantitative scoring system of 0 to 2 at baseline and follow-up. A total brain score was
calculated as the summed scores in the individual regions. In 7 patients, serial mean
diffusivity measurements were obtained. Age at baseline MRI, disease duration, atrophy,
codon 129methionine valine polymorphism, Medical Research Council Rating Scale score,
and histopathological findings were documented. The study setting was the National Prion
Clinic, London, England. All participants had a probable or definite diagnosis of sCJD and had
at least 2 MRI studies performed during the course of their illness. The study dates were
October 1, 2008 to April 1, 2012. The dates of our analysis were January 19 to April 20, 2012.
MAIN OUTCOMES ANDMEASURES Correlation of regional and total brain scores with disease
duration.
RESULTS Among the 37 patients with sCJD in this study there was a significant increase in the
number of regions demonstrating signal abnormality during the study period, with 59 of 62
regions showing increased signal intensity (SI) at follow-up, most substantially in the caudate
and putamen (P < .001 for both). The increase in themean (SD) total brain score from 30.2
(17.3) at baseline to 40.5 (20.6) at follow-up (P = .001) correlated with disease duration
(r = 0.47, P = .003 at baseline and r = 0.35, P = .03 at follow-up), and the left frontal SI
correlated with the degree of spongiosis (r = 0.64, P = .047). Decreasedmean diffusivity in
the left caudate at follow-up was seen (P < .001). Eight patients demonstrated decreased SI
in cortical regions, including the left inferior temporal gyrus and the right lingual gyrus.
CONCLUSIONS AND RELEVANCE Magnetic resonance images in sCJD show increased extent
and degree of SI on DWI that correlates with disease duration and the degree of spongiosis.
Although cortical SI may fluctuate, increased basal ganglia SI is a consistent finding and is due
to restricted diffusion. Diffusion-weighted imaging in the basal ganglia may provide a
noninvasive biomarker in future therapeutic trials.
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D iffusion-weighted imaging (DWI) has emerged as themost sensitive magnetic resonance imaging (MRI)sequence in the diagnosis of sporadic Creutzfeldt-
Jakob disease (sCJD),1-3 with studies4-6 showing its superior-
ity for detecting signal change in the cortex. Visual inspec-
tion of the trace-weighted diffusion image demonstrates
typically increased signal intensity (SI) in the cortex, with
up to 95% of cases showing hyperintensity affecting the
insula, cingulate, and superior frontal cortex independent
of deep gray matter involvement.3 The extent of involve-
ment and the distribution of signal changes vary among
patients and are thought to be influenced by PRNP (OMIM
123400) genotype and strain type of the abnormal isoform
of the prion protein.7,8 However, few studies9,10 have
assessed the evolution of these signal abnormalities as sCJD
progresses.
In the largest series to date of 8 patients with CJD having
serial DWI, therewas progression or constant lesion distribu-
tion, with increased SI in some lesions and decreased SI in
others.9 In 5 of 8 patients, a defined temporal sequence of
events was reported in which a high signal starts in the an-
teroinferior putamen and spreads to its posterior part, lead-
ing to complete involvementof theputamen.Another study10
describes the initial expansion of the signal changes but reso-
lution of the cortical signal change, with general progression
tocerebral atrophyat later stagesofCJD,and2other studies11,12
report thedisappearance of diffusion signal changes at termi-
nal stages of the disease.
The objective of this study was to assess the natural his-
tory of the MRI signal abnormalities on DWI in patients with
sCJD tobetter understand thepathogenesis of thedisease and
to develop a noninvasive measure of disease progression for
future therapeutic trials. Our hypothesis was that the extent
and degree of SI increases with sCJD progression.
Methods
Participants
The study setting was the National Prion Clinic, London,
England. In 2004, the chief medical officer wrote to UK neu-
rologists, requesting that all patients with suspected CJD are
referred to both the National CJD Research and Surveillance
Unit in Edinburgh, Scotland, and the National Prion Clinic
based at the National Hospital for Neurology and Neurosur-
gery inLondon.Magnetic resonance imagesofall patients seen
are sent to theNational PrionClinic indigital format. TheMRIs
studied herein came from patients who were referred to the
National Prion Clinic by their local physician between Octo-
ber 1, 2008, andApril 1, 2012, with full written informed con-
sent, and the patients were enrolled into either the PRION-1
clinical trial13 or the ongoing National Prion Monitoring
Cohort study.14 Both studies were approved by the Eastern
Medical Research Ethics Committee, London, and are
compliant with the Declaration of Helsinki.
We identified 37 consecutive participants with sCJD in
whom at least 2 serial MRI studies had been performed dur-
ing the course of their illness, with the inclusion of a DWI se-
quenceat each study.Themeanageat baselineMRIof thepar-
ticipants was 65.3 years (age range, 39-85 years), and 14were
female. In 4 participants inwhommultiple serialMRI studies
were obtained (3, 3, 3, and 4 studies, respectively), only the
initial baseline and the last available follow-up MRI scans
were included for analysis. Themean timebetweenMRI stud-
ieswas3.6months (range,0.5-29months). Thirtypatientshad
their MRI studies performed at the referring hospital, and
7 patients had their MRI studies performed at the National
Hospital for Neurology and Neurosurgery, London. All exter-
nal DWI studieswere performed at 1.5 or 3 T,with a b value of
1000s/mm2. Slightdifferences in section thicknesswere seen,
varying from3 to 5mm.Themeandisease duration at the ini-
tial MRI was 5.7 months. All patients had a clinical diagnosis
of sCJD based on the proposed World Health Organization
classification,15 confirmed by postmortem examination in 21
of 37 patients (57%). Details of the autopsy findings are listed
in eTable 1 in the Supplement. The remaining cases were di-
agnosed as probable sCJD according to accepted diagnostic
criteria.15 In all participants, age at baseline MRI, disease
duration, PRNP mutation analysis, codon 129 methionine
valine (MV) polymorphism, and clinical evaluation with the
Medical Research Council Rating Scale14 were documented.
MRI Acquisition
Seven patients underwent imaging at our institution, 3 on a
3-T MRI system (Tim Trio; Siemens) and 4 on a 1.5-T MRI
system (Signa LX; GE). For these patients, both baseline and
follow-upMRI studies were performed on the sameMRI sys-
tem. The 3-T diffusion-tensor imaging sequence consisted of
75sectionsof2.0-mmthickness,withabvalueof 1000s/mm2,
in 64 noncolinear directions (repetition time/echo time of
9500/93 milliseconds, 19.2-cm field of view, 96 × 96–pixel
matrix, and ameanof 1 signal),with8 imageshaving abvalue
of 0 s/mm2. The diffusion trace-weighted image and the
correspondingmean diffusivity (MD)mapwere generated by
the imaging system. At 1.5 T, DWI was performed using a
single-shot echoplanar technique (repetition time/echo
time of 10 000/101 milliseconds, 26-cm field of view,
96 × 128–pixelmatrix, 5-mmsection thickness, andameanof
1 signal), with diffusion-weighting factors (b values) of 0 and
1000 s/mm2 applied sequentially along 3 orthogonal axes.
MRI Visual Assessment
Signal Intensity
Two neuroradiologists (reader 1 [H.H.] with 9 years of expe-
rience in prion imaging and reader 2 [H.R.J.] with 25 years of
experience inprion imaging) independently reviewedallMRI
sequences. The readerswere aware of the clinical diagnosis of
sCJD in all patients, either confirmed after death or classified
as probable cases according to accepted diagnostic criteria.15
All images were viewed digitally on a workstation (Picture
Archiving and Communications System; Agfa) with facilities
for appropriatewindowing (adjustmentof SI) andSImeasure-
ments. AnyMRI studies performed externallywere uploaded
onto our in-houseworkstation andwerewindowed to appear
as similar as possible. Gray matter involvement on the diffu-
sion-weighted trace image was reported in 26 cortical and
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5 subcortical subdivisions per hemisphere.16 If a discrepancy
was identified, the images were rereviewed in a consensus
reading.Aκstatisticwas calculated toassess the level of agree-
ment between the 2 independent readers.
We used a semiquantitative scoring system that was
devised on 5 test cases by drawing a region of interest in
normal-appearing white matter and comparing the mean SI
in several cortical gray matter regions visually thought to be
normal, mildly hyperintense, and clearly hyperintense. The
semiquantitative scoring system was found to be robust.
A score of 0 indicated normal, with the SI within 2 SDs of
the white matter SI. A score of 1 indicated mildly hyperin-
tense, with the SI greater than 2 SDs above the white matter
SI but less than 2 times the white matter SI. A score of 2
indicated clearly hyperintense, with the SI at least 2 times
the white matter SI (eFigure 1 in the Supplement). To distin-
guish artifactual cortical DWI hyperintensity from true cor-
tical signal abnormality, the MD map was examined in con-
junction with the DWI image to identify corresponding
areas of hypointensity. A total brain score was calculated as
the summed scores in the individual regions (31 regions per
hemisphere), with the maximum total brain score being 124.
The aim was to assess both the extent and intensity of signal
abnormality in a particular MRI scan. A cortical score was
calculated as the sum of all 52 cortical regions, and a sub-
cortical score was calculated as the sum of 10 subcortical
regions.
Volume Loss
Frontal lobe, temporal lobe, parietal lobe, and generalized
cortical atrophy were individually assessed in each study
according to established criteria.17,18 A score of 0 indicated
normal, 1 indicated mild atrophy, 2 indicated moderate
atrophy, and 3 indicated severe atrophy.
Quantitative Assessment
Pixel-by-pixel MD maps were generated from the direction-
ally averaged imageswithbvalues of0 and 1000s/mm2using
the equation by Stejskal and Tanner 19 for MD calculation as
follows: MD = −[Inverse(S1 / S2) / (b1 − b2)], where S1 and S2
are the SIs of diffusion-weighted images with b values of
0 s/mm2 (b1) and 1000 s/mm2 (b2), respectively. The mean
MDs in 3 regions of interest were drawn on the left cerebral
hemisphere of the axial b0 image in the head of the left
caudate nucleus, left putamen, and frontal white matter
(volume,587-597mm3).The regionof interestmean fromeach
of the corresponding MDmaps was recorded.
Statistical Analysis
To assess change in SI from baseline to follow-up in a par-
ticular anatomical area, the Wilcoxon signed rank test was
used. Because 65 comparisons were performed, the P values
were adjusted to P ≤ .001 for statistical significance. To
assess correlation of total brain scores with age at baseline
MRI, disease duration, atrophy, and Medical Research Coun-
cil Rating Scale score, a Spearman rank correlation was per-
formed. Finally, to assess change in MD between baseline
and follow-up, the Wilcoxon signed rank test was used.
Quantitative Histopathological Analysis
Of the patients who underwent autopsy, the left frontal lobe
sections were acquired from 8 individuals for quantitative
analysis of the degree of spongiosis, calculated as the num-
ber of vacuoles per centimeter squared. Before analysis, all
slideswere reviewedbyanexperiencedneuropathologist. For
quality control purposes, slides that were found to be of poor
quality, such as those that were inadequately stained or
damaged, were replaced with newly acquired ones.
The slideswere scanned into adatabase (SlidePath; Leica)
and then loaded into awork space (Tissue Studio; Definiens).
A region of interestwasmanually selected thatwas free of ar-
tifact and then drawn. An analysis builder was used to per-
form the following functions: (1) define the magnification
strengthof×10, (2) apply abackground to tissue separation for
the analysis to be confinedpurely tobrain tissue, (3) select the
layer of tissue being analyzed, (4) apply homogeneity and
brightness thresholds, (5) select the stain being analyzed (eg,
hematoxylin-eosin), and (6) apply a stain threshold. Objects
above and below a specific contrast intensity could then be
deselected from the analysis. The degree of spongiosis was
correlated with disease duration at death and SI in the left
frontal cortex on MRI using the Spearman rank correlation
coefficient.
Results
Consensus Review
In the initial analysis, there was disagreement regarding
3 patients. The discrepancy was cortical region scores (κ sta-
tistic, 0.835). These images were rereviewed, and consensus
agreement was reached.
Baseline Analysis
Anatomical Regions
Thecortical region thatmost commonly showedsignal abnor-
mality in baseline studies (SI 1 or 2) was the posterior cingu-
lategyrus,with67%(28of37) involvementon the left and73%
(27 of 37) involvement on the right (there was no significant
differencebetween the left and the right). Thenextmost com-
monly involved regionwas the anterior cingulate gyrus, with
68% (25 of 37) involvement on the left and 65% (24 of 37) in-
volvement on the right, followed by the left superior frontal
gyrus, which showed signal abnormality in 65% (24 of 37) of
patients. The area least likely to be involved was the hippo-
campus and amygdala. Themean (SD) number of anatomical
regions involved at baseline was 21.8 (10.76) among 62 re-
gions, with slight asymmetry that was not significant (mean
[SD], 11.19 [5.79] regions in the lefthemisphereand10.59 [6.33]
regions in the right hemisphere) (Figure 1).
Signal Intensity
The greatest SI in baseline studies was seen in the anterior
cingulate gyrus (mean [SD], 1.00 [0.78] on the left and
1.00 [0.85] on the right) and the posterior cingulate gyrus
(mean [SD], 0.95 [0.78] on the left and 0.95 [0.85] on the
right), followed by the caudate nucleus (mean [SD], 0.89
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[0.77] on the left and 0.84 [0.76] on the right) and the left
superior frontal gyrus (mean [SD], 0.84 [0.73]) (Figure 2 and
eTable 2 in the Supplement). The least SI was seen in the
precentral gyrus, hippocampus and amygdala, and globus
pallidus.
Volume Loss
Frontal volume loss was most often seen, with a mean (SD)
score of 0.89 (0.62), followed by parietal volume loss, with a
mean (SD) score of 0.76 (0.89). Themean (SD) global atrophy
score of 0.54 (0.77)wasnextmost common type,withmesio-
temporal lobe atrophy rarely seen, having a mean (SD) score
of 0.16 (0.55).
Follow-upMRI
Anatomical Regions
There was a significant increase in the mean (SD) number of
anatomical regions demonstrating signal abnormality in
follow-up studies, with 28.0 (12.6) vs 21.8 (10.8) at baseline
(P = .001) and 13.8 (6.8) on the left (P = .004) and 14.2 (7.0)
on the right (P < .001). Figure 3A-D shows the increase in the
extent of cortical signal abnormality in follow-up studies.
Figure 1. Anatomical Distribution of Diffusion-Weighted Imaging Signal
Intensity at Baseline and Follow-up
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Shown are percentages of participants with diffusion-weighted imaging signal
intensity of 1 or 2 in each of 31 brain regions at baseline (light blue) and
follow-up (dark blue). L indicates left; R, right.
aP < .05.
Figure 2. Average Signal Intensity in Each Region at Baseline
and Follow-up
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Signal Intensity
On average, 59 of 62 regions showed increased SI at follow-
up. The regions that showed the greatest increase in SI were
the caudate, with a mean (SD) of 0.89 (0.77) for baseline left
vs 1.38 (0.72) for follow-up left and amean (SD) of 0.84 (0.76)
for baseline right vs 1.35 (0.77) for follow-up right (P < .001 for
both)andtheputamen,withamean(SD)of0.70 (0.71) forbase-
line left vs 1.19 (0.70) for follow-up left andamean (SD)of0.62
(0.64) for baseline right vs 1.11 (0.74) for follow-up right
(P < .001 for both) (Figure 2 and eTable 2 in the Supplement).
Examples of this increase in basal ganglia SI are shown in
Figure 3D and J. The right inferior frontal gyrus showed the
next largest increase in SI (Figure 2). The left middle tempo-
ral gyrus remained stable in SI at follow-up.
Figure 3. Typical Examples of Change in the Extent and Intensity of Signal Abnormality on Diffusion-Weighted Imaging
A B I J
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Baseline Follow-up Baseline Follow-up
A-H, Shown are axial diffusion-weighted images in a 66-year-old womanwith
the codon 129methionine valine polymorphism. A and B, The left
temporo-occipital cortical signal abnormality (A) progresses to bilateral
temporo-occipital cortical signal abnormality at follow-up 30months later
(arrowhead) (B). C and D, Signal intensity 0 in the right putamen at baseline (C)
progresses to signal intensity 2 (arrowheads) and new right lateral occipital
cortical signal abnormality at follow-up (arrow) (D). E and F, Bifrontal and
biparietal cortical signal abnormality (E) progresses to increased right superior
parietal cortical signal abnormality at follow-up (F). The arrowheads in F
indicate increased right superior parietal signal abnormality. Note that the
cortical signal abnormality progresses in contiguous cortical areas. G and H,
Coronal T1-weighted images show progression of central and parietal atrophy
from baseline (G) to follow-up (H). The arrow in H indicates increased central
atrophy on follow-up. I and J, Axial diffusion-weighted images in a 60-year-old
womanwith the codon 129 valine homozygous polymorphism show an increase
in caudate and thalamic signal intensity (arrows) from baseline (I) to follow-up 4
months later (J). K-P, Shown are axial diffusion-weighted images in a 53-year-old
womanwith the codon 129methionine homozygous polymorphism.
K-N, Baseline (K andM) and follow-up (L and N) axial diffusion-weighted images
show decrease in cortical signal abnormality in the occipital lobes (arrowheads)
at follow-up (L) compared with baseline (K) and decrease in cortical signal
abnormality in the parietal lobes (arrowheads) at follow-up (N) compared with
baseline (M). O and P, T1-weighted coronal images show progression of central
and perisylvian atrophy (arrow) from baseline (O) to follow-up (P).
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Volume Loss
Therewas an increase in all atrophy scores in follow-up stud-
ies, with amean (SD) of 0.92 (0.76) for frontal, 0.76 (0.86) for
global, 0.89 (0.97) for parietal, and 0.35 (0.72) for mesiotem-
poral. Themost significant increasewas found in global atro-
phy (P = .009). These results are shown in Figure 3H and P.
Total Brain Score
In total, 29of37patients showedan increase in totalbrainscore
on follow-upMRI.On average, themean (SD) total brain score
increased from 30.2 (17.3) to 40.5 (20.6) (P = .001). This in-
creasewasdue toan increase in themean (SD) cortical SI, from
26.0 (19.1) to 35.3 (22.2) (P = .005) and in the mean (SD) sub-
corticalSI from4.5 (4.0) to6.5 (4.3) (P = .008).Therewasaposi-
tive correlation between baseline (r = 0.47, P = .003) and fol-
low-up (r = 0.35,P = .03) total brain scoreanddiseaseduration
(Figure4) butno correlationbetween total brain score andage
at baseline MRI, atrophy, and Medical Research Council Rat-
ing Scale score.
The remaining 8 patients showed a decrease in total
brain score on follow-up study owing to a decrease in SI in
cortical regions (from 35.1 to 25.0, a 29% decrease) but not in
subcortical regions (from 2.8 to 5.9, a 53% increase)
(Figure 3K-P). When we compared the patients who showed
a decrease in total brain score with the patients who showed
an increase in total brain score at follow-up, we found a
slight increase in global atrophy scores (mean [SD], 0.79
[0.92] vs 0.71 [0.77]). We also found more patients with the
codon 129 MV polymorphism (4 of 8 patients in the group
that showed a decrease in total brain score had the codon
129 MV polymorphism compared with 7 of 29 patients in the
group that showed an increase in total brain score.) Neither
finding reached statistical significance. In addition, no sig-
nificant difference was found in age at baseline MRI, disease
duration, time to death, or Medical Research Council Rating
Scale score.
Mean Diffusivity
In 7 patientswhounderwent imaging at our institution, serial
MDmeasurements showeda significant decrease inMD in the
left caudate and left putamen in follow-up studies compared
with baseline studies (Figure 5). The mean (SD) left caudate
MD was 646.1 (99.5) ×10−3 mm2/s at baseline compared with
591.1 (89.7) 10−3mm2/s at follow-up (P < .001). Themean (SD)
left putamen MD was 591.1 (123.6) 10−3 mm2/s at baseline vs
531.2 (99.0) 10−3 mm2/s at follow-up (P = .05). However, no
significant difference was seen for frontal white matter.
Quantitative Histopathological Analysis
Clinical details of 8 patientswhounderwent quantitative his-
topathological analysis are listed in eTable 1 in the Supple-
ment.Therewasasignificant correlationbetween the left fron-
talMRI SI and thenumber of vacuoles per centimeter squared
in the left frontal cortex (r = 0.64,P = .047) (eFigure 2A in the
Supplement). There was also a significant correlation be-
tween disease duration at death and the number of vacuoles
per centimeter squared in the left frontal cortex (r = 0.65,
P = .04) (eFigure 2B in the Supplement).
Discussion
To our knowledge, this study is the largest to date to
describe the evolution of MRI signal abnormality on DWI in
patients diagnosed as having sCJD, with histopathological
correlation in a subgroup. We have shown that disease pro-
gression is accompanied by an increase in both the extent
and intensity of signal abnormality. The basal ganglia
showed a consistent and the most significant increase in SI
as sCJD progresses. Measurements of MD performed in a
subgroup showed that signal increase on the trace-weighted
DWI images suggests restriction of water diffusion. In most
patients with sCJD, disease progression is also associated
with an increase in cortical signal abnormalities, which cor-
relates with the degree of spongiosis. However, in some
patients, we have seen a decrease in the extent and intensity
of cortical signal abnormality, which is a potential pitfall of
which physicians should be made aware.
Although the distribution of cortical and subcortical sig-
nal abnormality in sCJD has been well characterized in large
cohorts,2,4-6,16,20 few studies have examined the evolution of
Figure 4. Correlation of Total Brain ScoreWith Disease Duration
at Baseline and Follow-up
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signal abnormality in sCJD. In the largest series to date of
8 patientswith serial imaging,9 striatal involvementwas seen
in 7 of 8 patients in the final study. In another study21 of serial
MRI in 6 patients with sCJD, 3 of 5 patients with only cortical
lesions seenon the initial studyprogressed tobasal ganglia in-
volvement and increased cortical involvement in the subse-
quent studies. In a single case report, increased basal ganglia
and thalamic signal abnormalitywas seen on the thirdMRI at
9 months.22 In our study, the caudate and putamen were the
most commonly involved subcortical regions and showed the
greatest SI on follow-up study.
Involvement of the thalamus and striatum is well estab-
lished in sCJD.23 The putamen and caudate nuclei receive in-
put from diverse cortical areas, including prefrontal and lim-
bic structures, with nonmotor output from the striatum
projecting via the mediodorsal and ventrolateral thalamic
nuclei to thedorsolateral prefrontal cortex, lateral orbitofron-
tal cortex, and anterior cingulate.20 These subcortical struc-
tures appear to be increasingly involved as the disease pro-
gresses in sCJD, perhaps reflecting increased cortical
involvement with disease duration as demonstrated in this
study.
Diffusion-weighted imaging hyperintensity is thought to
be owing to a combination of diffusion restriction and T2-
weightedprolongation. Studies12,24,25 that havemeasuredMD
insCJDhaveshowndecreasedMDinthecaudate,putamen,and
thalamus. LongitudinalMDmeasurements in sCJD have dem-
onstrated conflicting data, with one study9 reporting de-
creasedMDinthestriatumduring2weeksandotherstudies12,26
reporting increasedMD in thebasal gangliaMDover time, sug-
gesting that MD may vary according to the disease stage. We
found a significant decrease in MD in the caudate and puta-
men at follow-up in our institution. Some changes in indi-
vidual patients were modest, while other patients demon-
stratedmore rapidchange. Severe spongiformchange, causing
cell swellingandrestricting theextracellular space,hasbeenad-
vocatedasapotential causeofdecreasedMD,27,28 and it is likely
that increased spongiform degeneration as CJD progresses
reducesMD in the subcortical structures even further.
The distribution of cortical signal abnormality in our
study is in line with previous studies2,3,16 reporting that the
frontal, limbic, and parietal lobes are predominantly
involved, with relative sparing of the precentral and central
gyri. These cortical signal changes correspond anatomically
to the prominent cognitive features of memory loss and
frontal executive dysfunction seen in prion diseases,29
although subcortical circuits are likely to be involved. We
found not only that these cortical regions were most com-
monly involved with the highest SI at baseline but also that
these regions all showed an increase in the extent and
degree of SI over time. The degree of SI in the left frontal
cortex correlated with the degree of spongiosis.
An increase in theextentofcortical signalabnormalitywith
disease progression has previously been reported in sCJD.9-11
Among 6 patients in whomDWI signal abnormality was seen
in the cortex on anearly scan, the cortical signal in 2 of thepa-
tients progressed from asymmetrical to symmetrical abnor-
malitieson follow-upstudy.11 Inanother singlecase report, cor-
tical signal abnormality progressed fromcingulate, calcarine,
and left temporal cortex involvement to also include the left
temporoparietal cortex on follow-up study 3 months later.10
We have not only shown an increase on average in the extent
ofcortical signalabnormalityas thediseaseprogresses ina large
cohort of patientswith sCJD, butwe also describe an increase
in the degree of SI in specific cortical brain regions, with the
inferior frontalgyrusbeing thecortical regionshowing the larg-
est increase inSI in follow-upstudies.Wehavealso shownthat
in a subgroup of patients the left frontal cortical SI correlates
with the degree of spongiosis, in line with previous
studies.26,30,31Thecombinationofan increase in theextentand
degree of SI, as captured in a total brain score, correlateswith
disease duration and is likely to reflect increased spongiform
degeneration as CJD progresses.
Most patients herein had an increase in total brain score
on follow-up MRI, but we observed a decrease in total brain
score in 8 of our patients. The decrease was owing to
decreased cortical SI but not subcortical SI, and the areas
that showed the greatest decrease were the left inferior tem-
Figure 5. Change in Basal Ganglia Mean Diffusivity Over Time
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poral gyrus and the right lingual gyrus. The disappearance
or decreased conspicuity of DWI cortical signal has been
previously reported in the literature and was attributed
anecdotally to increased atrophy at the end stage of CJD.10,11
Our observations herein in a larger cohort of patients con-
firm the dynamic nature of the cortical DWI signal abnor-
mality in sCJD. We noted a slightly higher atrophy score on
follow-up MRI study in patients in whom cortical signal
abnormality decreased, which did not reach statistical
significance, possibly because of the few patients in the
cohort. It is likely that as the disease progresses, neuronal
death and loss cause augmentation of the extracellular
space, with increased diffusion and decreased DWI signal
abnormality before there is frank atrophy.
Among 8 patients with decreased cortical signal abnor-
mality at follow-up, we also found a higher proportion of pa-
tientswhowere heterozygous at codon 129MV. Although the
numbers are small and this findingneeds to be confirmed in a
larger cohort, it is known that patterns of MRI signal abnor-
mality in sCJD are influenced by codon 129 MV polymor-
phism status.7 Therefore, it is possible that the evolution of
signal abnormality is also influenced by codon 129 MV poly-
morphism status, reflecting the known longer disease
duration.32
Limitations of the study include the subjective nature of
the semiquantitativeMRI analysis,MRI studies performedon
differentMRIsystemsthatdiffered inscanparametersandfield
strength, and the fact that theMRI readers had knowledge of
the clinical diagnosis of sCJD in all patients. All images were
viewed on an off-line workstation with appropriate window-
ing to limit these variables. The few patients included in the
quantitativehistopathological analysis is also apotential limi-
tation. The study needs to be repeated in a larger cohort with
moreextensivequantitativehistopathologicalanalysisandMRI
correlation.
Conclusions
Patients with sCJD show an increase in the extent and degree
of signal abnormality in cortical and subcortical regions that
correlates with disease duration and the degree of spongio-
sis. Although cortical signal abnormalitymay fluctuate, an in-
crease inbasal ganglia SIwas a consistent finding thatwasdue
to an increase in restrictionof diffusion.Diffusion abnormali-
ties in thebasal ganglia in sCJDmayprovideanoninvasivebio-
marker of disease severity for future therapeutic trials that
needs to be confirmed in larger studies.
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